The NHLBI Lymphangioleiomyomatosis Registry-Reference-Cited by-同舟云学术

The NHLBI Lymphangioleiomyomatosis Registry

Published:2006-01 Issue:1 Volume:173 Page:105-111
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Ryu Jay H.,Moss Joel,Beck Gerald J.,Lee Jar-Chi,Brown Kevin K.,Chapman Jeffrey T.,Finlay Geraldine A.,Olson Eric J.,Ruoss Stephen J.,Maurer Janet R.,Raffin Thomas A.,Peavy Hannah H.,McCarthy Kevin,Taveira-DaSilva Angelo,McCormack Francis X.,Avila Nilo A.,DeCastro Rosamma M.,Jacobs Susan S.,Stylianou Mario,Fanburg Barry L.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference38 articles.

1. Lymphangioleiomyomatosis

2. Rare diseases bullet 1: Lymphangioleiomyomatosis: clinical features, management and basic mechanisms

3. Lymphangioleiomyomatosis

4. Lymphangioleiomyomatosis

5. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors.

Cited by 391 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Manifestations of Systemic Diseases;Pulmonary Pathology;2025

2. Omics research in lymphangioleiomyomatosis: status and challenges;Expert Review of Respiratory Medicine;2024-09-11

3. Surgical Management of Solitary Extrapulmonary Lymphangioleiomyomatosis in the Mesentery: A Case Report;Cureus;2024-09-09

4. Clinical and functional outcomes associated with quality of life in patients with lymphangioleiomyomatosis: a cross-sectional study;2024-08-10

5. PMEL is a predictive biomarker for mTORC1 inhibitor treatment of renal angiomyolipoma in tuberous sclerosis complex patients;Heliyon;2024-08